NLGN3 — Neuroligin-3
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NLGN3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NLGN3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Neuroligin 3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>54413</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>300336</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000174373</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NZU4</td>
</tr>
<tr>
<td class="label">Gene Size</td>
<td>~36 kb</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>19</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,461 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~165 kDa</td>
</tr>
<tr>
<td class="label">Synapse Type</td>
<td>NLGN3 Contribution</td>
</tr>
<tr>
<td class="label">Excitatory (glutamatergic)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Inhibitory (GABAergic)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Mixed/ambiguous</td>
<td>Specific</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">NRXN1 (Neurexin-1)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>
<td class="label">NRXN2 (Neurexin-2)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>
<td class="label">NRXN3 (Neurexin-3)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>
<td class="label">PSD-95 (DLG4)</td>
<td>PDZ-domain binding</td>
</tr>
<tr>
<td class="label">SAP97 (DLG1)</td>
<td>PDZ-domain binding</td>
</tr>
<tr>
<td class="label">Shank1/2/3</td>
<td>Indirect (via PSD-95)</td>
</tr>
<tr>
<td class="label">Homer1/2/3</td>
<td>Indirect via scaffold</td>
</tr>
<tr>
<td class="label">Dystrophin</td>
<td>Alternative scaffold</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>NLGN3 Expression</td>
</tr>
<tr>
<td class="label">Pyramidal neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">GABAergic interneurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Dopaminergic neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Astroglia</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Very low</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ischemic-brain-injury" style="color:#ef9a9a">Ischemic Brain Injury</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">glioblastoma</a>, <a href="/wiki/high-grade-gliomas" style="color:#ef9a9a">high-grade gliomas</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">25 edges</a></td>
</tr>
</table>
Overview
NLGN3 (Neuroligin-3) encodes a postsynaptic cell adhesion molecule that is essential for the formation, function, and plasticity of synapses throughout the mammalian brain. As a member of the neuroligin family, NLGN3 mediates trans-synaptic adhesion by binding to presynaptic neurexins (NRXN1, NRXN2, NRXN3), forming a physical bridge that aligns presynaptic release machinery with postsynaptic signaling apparatus [@sudhof2008]. NLGN3 is widely expressed in neurons throughout the brain, with particularly high levels in the cerebral cortex, hippocampus, and basal ganglia.
Mutations in NLGN3 were among the first gene discoveries in monogenic autism spectrum disorder (ASD), establishing a direct link between synaptic adhesion molecules and social cognition [@jamain2003]. The R451C substitution in NLGN3 causes a missense mutation that alters the protein's ability to form inhibitory synapses, providing a molecular basis for the excitatory/inhibitory imbalance hypothesis of autism. Beyond ASD, NLGN3 is implicated in Alzheimer's disease (AD) and Parkinson's disease (PD), where amyloid-beta and alpha-synuclein pathology, respectively, disrupt NLGN3-mediated synaptic adhesion, contributing to synaptic dysfunction and cognitive decline [@giacomucci2017][@bissiere2021].
Gene and Protein Structure
Genomic Organization
Protein Architecture
NLGN3 is a type I transmembrane protein with distinct structural domains [@sudhof2008]:
Mermaid diagram (expand to render)
Signal peptide (aa 1-30): N-terminal signal sequence directing protein to the secretory pathway
Esterase-like domain (aa 31-640): Acetylcholinesterase-homologous region that contains the primary neurexin-binding interface. This domain mediates the trans-synaptic interaction with presynaptic neurexins and is critical for synapse specification
Glycine-rich region (aa 641-730): Flexible spacer connecting the extracellular domain to the membrane
Transmembrane helix (aa 731-753): Single-pass transmembrane anchor
Intracellular domain (aa 754-1461): Contains multiple interaction motifs including a PDZ domain-binding motif at the C-terminus (X-S/T-X-V) that recruits PSD-95, SAP97, and other scaffolding proteins to organize the postsynaptic density [@varea2010]Splice Variants
NLGN3 undergoes extensive alternative splicing, with at least three principal isoforms identified:
- NLGN3 variant A (canonical): Full-length isoform with all functional domains
- NLGN3 variant B: Alternative splicing in the intracellular domain, affecting PDZ-binding interactions
- NLGN3 variant C: Truncated form expressed during early development
The splice site at intron 7 (site A) and intron 15 (site B) produce isoforms with different properties. Site A insertion influences neurexin-binding affinity, while site B affects intracellular protein interactions.
Biological Functions
Trans-Synaptic Adhesion
NLGN3 functions as a master organizer of synaptic connectivity through its interaction with presynaptic neurexins [@sudhof2008]:
Neurexin Binding Mechanism:
- The esterase-like domain of NLGN3 forms a high-affinity complex with the LNS domain of neurexins
- Neurexin binding is calcium-dependent and highly specific
- Each neuroligin can bind multiple neurexin isoforms, creating combinatorial specificity
Synapse Formation Pathway:Mermaid diagram (expand to render)
Initial contact: NLGN3 on the postsynaptic membrane interacts with neurexins on the presynaptic terminal
Bidirectional signaling: The neurexin-neuroligin complex transduces signals in both directions
Synaptic differentiation: Intracellular domains recruit scaffolding proteins and organize synaptic machinery
Synapse stabilization: Mature synapses are maintained through ongoing adhesionSynaptic Specificity
NLGN3 contributes to the molecular code that specifies synapse types:
Unlike NLGN1 (excitatory-specific) and NLGN2 (inhibitory-specific), NLGN3 contributes to both excitatory and inhibitory synapses, conferring unique flexibility in synaptic circuit organization.
Synaptic Plasticity
NLGN3 is dynamically regulated by synaptic activity and plays a critical role in experience-dependent plasticity [@varea2010][@bethge2015]:
Activity-dependent trafficking: NMDA receptor activation drives NLGN3 to the postsynaptic membrane
Local translation: NLGN3 mRNA can be translated in dendrites, allowing rapid local protein synthesis
LTP regulation: NLGN3 is required for proper long-term potentiation in the hippocampus
LTD regulation: NLGN3 loss impairs long-term depression and memory extinction
Homeostatic plasticity: NLGN3 levels adjust to maintain synaptic balance during prolonged activity changesIntracellular Signaling
The NLGN3 intracellular domain recruits multiple signaling proteins:
- PSD-95 (DLG4): Primary scaffold that organizes the postsynaptic density and clusters glutamate receptors [@tabuchi2007]
- SAP97 (DLG1): MAGUK family protein involved in receptor trafficking
- Shank proteins: Bridge PSD-95 to the actin cytoskeleton
- Homer: Links NLGN3 to metabotropic glutamate receptors
- SRc family kinases: Phosphorylate NLGN3 and modulate its interactions
Disease Associations
Autism Spectrum Disorder
NLGN3 mutations represent one of the most robust genetic links to monogenic autism [@jamain2003][@nava2014]:
R451C Missense Mutation:
The R451C substitution (arginine to cysteine at position 451) was identified in Swedish families with ASD and intellectual disability. Functional studies revealed:
- Increased inhibitory synaptic transmission without changing excitatory transmission
- Impaired social behavior in knock-in mice
- Altered GABAergic synapse morphology [@tabuchi2007][@tanaka2012]
- The mutation enhances NLGN3 protein stability, increasing its presence at inhibitory synapses
Additional ASD-Associated Mutations:
- Missense mutations disrupting the esterase-like domain (affecting neurexin binding)
- Frameshift mutations causing premature termination
- Splice-site mutations altering isoform expression [@bemben2015]
- 15q11.2 microdeletions encompassing NLGN3 [@kumar2013]
Mechanistic Insights:
- Mutations disrupt the balance of excitatory/inhibitory (E/I) transmission
- Altered synapse formation and function in cortical and hippocampal circuits
- Impaired social cognition and behavioral flexibility
Alzheimer's Disease
NLGN3 is progressively downregulated in AD brain tissue, contributing to synaptic failure [@giacomucci2017][@duke2020]:
Synaptic loss correlation: NLGN3 protein levels correlate with cognitive scores in AD patients
Aβ-mediated disruption: Amyloid-beta oligomers reduce NLGN3 expression in hippocampal neurons
Impaired homeostatic plasticity: NLGN3 knockdown disrupts synaptic scaling in AD models
Excitatory/inhibitory imbalance: Aβ-induced NLGN3 changes shift the E/I ratio toward hyperexcitability
Memory deficits: NLGN3 reduction contributes to hippocampus-dependent memory impairmentParkinson's Disease
NLGN3 alterations in PD reflect synaptic vulnerability in dopaminergic circuits [@bissiere2021]:
Frontal cortex reduction: NLGN3 is decreased in PD frontal cortex, mirroring AD patterns
Alpha-synuclein effects: α-synuclein oligomers reduce NLGN3 in neuronal cultures
Synaptic dysfunction: NLGN3 changes precede or accompany motor symptom onset
Cognitive co-morbidity: NLGN3 levels correlate with PD dementia severity
Dopaminergic circuit disruption: Impaired NLGN3 function in striatal and cortical synapsesIntellectual Disability
NLGN3 mutations cause X-linked intellectual disability with variable phenotypes:
- Moderate to severe intellectual disability in males
- Carrier females may show milder cognitive effects
- Frequently associated with ASD features and motor coordination deficits
Molecular Mechanisms
The structural basis of neurexin-neuroligin adhesion involves:
Mermaid diagram (expand to render)
Key features:
- Calcium ions bridge the interface between neurexin and NLGN3
- NLGN3 forms homodimers via its esterase domain, doubling the adhesion strength
- The complex can recruit both excitatory and inhibitory machinery
Signaling Cascade
Upon neurexin binding, NLGN3 triggers intracellular signaling:
PDZ recruitment: C-terminal PDZ-binding motif recruits PSD-95 family proteins
Scaffold assembly: PSD-95 assembles a complex with NMDA receptors, AMPARs, and signaling molecules
Receptor trafficking: SAP97 and other MAGUK proteins regulate receptor insertion/removal
Cytoskeletal organization: Shank and Homer link the scaffold to actin filaments
Gene transcription: Long-term changes are mediated via CREB and other transcription factorsActivity-Dependent Regulation
NLGN3 is dynamically regulated by neural activity [@varea2010]:
- NMDA-dependent: Activity increases NLGN3 surface expression via NMDA receptor activation
- CaMKII phosphorylation: CaMKII phosphorylates NLGN3, enhancing its synaptic stability
- Ubiquitin-mediated turnover: Activity-dependent ubiquitination controls NLGN3 levels
- ADAM10 cleavage: Proteolytic shedding of NLGN3 extracellular domain regulates synaptic plasticity
Interaction Network
Core Synaptic Partners
Regulators and Modifiers
- ADAM10/ADAM17: Proteolytic cleavage of NLGN3 extracellular domain
- CaMKII: Phosphorylation site at serine 841
- Ubiquitin ligases (Parkin, Trim3): Regulate NLGN3 degradation
- Rho GTPases (Cdc42, Rac1): Control NLGN3 trafficking to synapses
- SUMOylation: Modifies NLGN3 function and interactions
Disease-Relevant Interactions
In Alzheimer's Disease:
- Interacts with APP and Aβ processing machinery
- Disrupted by amyloid-beta oligomers
- Modulated by BACE1 and γ-secretase activity
In Parkinson's Disease:
- Affected by α-synuclein oligomers
- Modulated by LRRK2 kinase activity
- Linked to parkin-mediated quality control
Animal Models
Knockout Mice
Nlgn3 knockout mice exhibit:
- Reduced inhibitory synaptic transmission in cortex and hippocampus
- Impaired social interaction and preference for social novelty
- Enhanced spatial learning in some contexts
- Increased aggressive behavior
- Sex-specific phenotypes reflecting X-chromosome inactivation
R451C Knock-in Mice
The autism-associated R451C mutation in knock-in mice [@tabuchi2007][@tanaka2012]:
- 15-30% increase in inhibitory synaptic transmission
- Normal excitatory transmission
- Impaired social behavior and ultrasonic vocalizations
- Enhanced spatial learning (contradictory to human phenotype)
- Altered NMDA receptor composition at synapses
Conditional/Adult Knockout
Conditional deletion in adulthood [@sun2019]:
- Impaired memory consolidation and retrieval
- Reduced LTP in hippocampal slices
- Reversible phenotypes suggest ongoing NLGN3 function in adults
- Supports therapeutic potential of NLGN3 restoration
Rescue Experiments
Gene therapy approaches have demonstrated [@rodriguez2022]:
- AAV-mediated NLGN3 delivery to Nlgn3 knockout mice restores social behavior
- Critical time window: early postnatal delivery more effective than adult
- Circuit-specific effects depending on delivery site
- Proof-of-concept for human gene therapy approaches
Therapeutic Implications
Gene Therapy
NLGN3 represents a promising target for monogenic autism [@rodriguez2022]:
- AAV9 vectors can cross the blood-brain barrier and deliver functional NLGN3
- Viral vector engineering improves neuronal transduction
- Optimal delivery window during early development
- Challenges: X-linked expression, mosaic inactivation in females
Small Molecule Approaches
- Neurexin enhancers: Compounds that stabilize neurexin-NLGN3 interactions
- Synaptic adhesion modulators: Molecules that promote NLGN3 surface expression
- Activity-dependent enhancement: Drugs that upregulate NLGN3 through neural activity
biomarker Potential
NLGN3 and its interacting proteins serve as synaptic biomarkers:
- Soluble NLGN3 fragments in cerebrospinal fluid
- Synaptic NLGN3 levels in post-mortem brain
- Correlation with cognitive scores in AD and PD
Expression Pattern
Brain Regional Expression
High expression in:
- Cerebral cortex: Layers 2-3 and 5-6 pyramidal neurons
- Hippocampus: CA1 and CA3 pyramidal cells, dentate granule neurons
- Basal ganglia: Striatal medium spiny neurons, dopaminergic target cells
- Amygdala: Principal neurons of basolateral complex
- Cerebellum: Purkinje cells and deep cerebellar nuclei
Lower expression in:
- Brainstem respiratory centers
- Spinal cord motor neurons
- Peripheral nervous system
Cell-Type Specificity
Cross-Links
- [NLGN1](/genes/nlgn1) — Neuroligin-1, excitatory-specific
- [NLGN2](/genes/nlgn2) — Neuroligin-2, inhibitory-specific
- [NLGN4X](/genes/nlgn4x) — Neuroligin-4X, autism-associated
- [NRXN1](/genes/nrxn1) — Neurexin-1, primary NLGN3 partner
- [NRXN2](/genes/nrxn2) — Neurexin-2, synaptic partner
- [NRXN3](/genes/nrxn3) — Neurexin-3, alternative partner
- [PSD-95/DLG4](/genes/dlg4) — Postsynaptic scaffold
- [Synaptic Adhesion Molecules](/mechanisms/synaptic-adhesion-molecules) — Neurexin-NLGN complex
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity) — LTP and LTD
- [Long-term Potentiation](/mechanisms/long-term-potentiation) — Hippocampal memory
- [Excitatory-Inhibitory Balance](/mechanisms/excitatory-inhibitory-balance) — Circuit function
- [Neuroinflammation](/mechanisms/neuroinflammation) — Synaptic effects
- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder) — Primary genetic link
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Synaptic dysfunction
- [Parkinson's Disease](/diseases/parkinsons-disease) — Synaptic vulnerability
- [Intellectual Disability](/diseases/intellectual-disability) — X-linked form
- [Neurexin Signaling Pathway](/mechanisms/neurexin-signaling)
- [Postsynaptic Density Organization](/mechanisms/postsynaptic-density-organization)
- [GABAergic Synapse Formation](/mechanisms/gabaergic-synapse-formation)
- [AMPA Receptor Trafficking](/mechanisms/ampa-receptor-trafficking)
Pathway Diagram
The following diagram shows the key molecular relationships involving NLGN3 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)